4//SEC Filing
Boesgaard Lars 4
Accession 0001140361-23-056240
CIK 0001472091other
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 6:14 PM ET
Size
5.5 KB
Accession
0001140361-23-056240
Insider Transaction Report
Form 4
Boesgaard Lars
Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2023-12-04+200,000→ 200,000 totalExercise: $5.28Exp: 2033-12-04→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]The option was granted by the Issuer as an inducement material to the Reporting Person entering into employment with the Issuer in accordance with Nasdaq Rule 5635(c)(4) and the Issuer's 2019 Inducement Plan, as amended. The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on December 4, 2024, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.
Documents
Issuer
PDS Biotechnology Corp
CIK 0001472091
Entity typeother
Related Parties
1- filerCIK 0001403893
Filing Metadata
- Form type
- 4
- Filed
- Dec 3, 7:00 PM ET
- Accepted
- Dec 4, 6:14 PM ET
- Size
- 5.5 KB